Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis.

Published on Sep 1, 2001in Journal of Clinical Gastroenterology2.973
· DOI :10.1097/00004836-200109000-00019
Claudio Farina20
Estimated H-index: 20
Marco Arosio3
Estimated H-index: 3
+ 1 AuthorsFausto Moioli1
Estimated H-index: 1
AbstractLactobacillus species are part of normal gastrointestinal flora and are an uncommon cause of bacteremia. Lactobacillus casei subsp. rhamnosus was repeatedly isolated in the blood cultures of a 43-year-old woman with ulcerative colitis. Lactobacillus spp. could be considered a potential oppor
📖 Papers frequently viewed together
285 Citations
346 Citations
475 Citations
#1Christopher D. Cooper (USF: University of South Florida)H-Index: 2
#2Albert L. Vincent (USF: University of South Florida)H-Index: 12
Last. Ledya Cobian (USF: University of South Florida)H-Index: 3
view all 5 authors...
22 CitationsSource
#1Rola N. Husni (Cleveland Clinic)H-Index: 6
#2Steven M. Gordon (Cleveland Clinic)H-Index: 53
Last. David L. Longworth (Cleveland Clinic)H-Index: 33
view all 4 authors...
Lactobacilli are part of normal gastrointestinal and genitourinary flora but are an uncommon cause of bacteremia. We reviewed the cases of 45 patients with clinically significant lactobacillus bacteremia occurring over 15 years. Underlying conditions were common, including cancer (40%), recent surgery (38%), and diabetes mellitus (27%). Twenty-two patients were in the intensive care unit at the time of onset of lactobacillus bacteremia. Eleven of the 45 patients were receiving immunosuppressive ...
214 CitationsSource
#1Suresh J. Antony (Vandy: Vanderbilt University)H-Index: 6
#2Charles W. Stratton (Vandy: Vanderbilt University)H-Index: 50
Last. J. S. Dummer (Vandy: Vanderbilt University)H-Index: 2
view all 3 authors...
Lactobacillus bacteremia in the absence of endocarditis is a rare entity, and the clinical relevance of such bacteremia remains unclear. The clinical courses of lactobacillus bacteremia without endocarditis in 43 previously described patients and 12 new patients were reviewed. Bacteremia with Lactobacillus alone occurred in 34 (62%) of the patients, and 12 (22%) of the patients had bacteremia with other organisms, including Lactobacillus. Lactobacillus was isolated from another site in 18 (33%) ...
91 CitationsSource
#1Robin Patel (Mayo Clinic)H-Index: 95
#2Franklin R. Cockerill (Mayo Clinic)H-Index: 49
Last. Michael R. Keating (Mayo Clinic)H-Index: 20
view all 6 authors...
Lactobacillemia is rare and, to our knowledge, previously undescribed in liver transplant patients. We reviewed the clinical records of all patients who had undergone orthotopic liver transplantation between January 1985 and August 1992 for whom a blood culture after transplantation yielded Lactobacillus species. A case-control study for determination of risk factors for lactobacillemia in this patient population was also performed. Eight cases of lactobacillus bacteremia were identified. All pa...
90 CitationsSource
#1Bruce Toporoff (UA: University of Arizona)H-Index: 4
#2Luis J. RosadoH-Index: 11
Last. Jack G. CopelandH-Index: 61
view all 5 authors...
: We report a case of bacterial endocarditis in a heart transplant recipient that was diagnosed 6 weeks after operation when a transesophageal echocardiogram revealed vegetations on both sides of the atrial septum. The patient also had postoperative mediastinitis and pericarditis. He underwent two mediastinal explorations, pericardiectomy, and 22 weeks of antibiotics and is free of infection 1 year after transplantation. We presume that the source of infection was contamination of the donor hear...
20 Citations
Eighteen isolates of Bifidobacterium species, 99 of Eubacterium species, and 38 of anaerobic Lactobacillus species were recovered from 3,971 clinical specimens submitted to the anaerobic microbiology laboratory at the National Naval Medical Center over a period of 10 years (June 1978 to June 1988). Clinically significant infection was documented in association with 53 isolates recovered from 52 patients: 8 (44%) of the 18 Bifidobacterium isolates, 30 (30%) of the 99 Eubacterium isolates, and 15 ...
67 CitationsSource
#1Jeffrey K. Griffiths (Tufts University)H-Index: 36
#2Jennifer S. DalyH-Index: 17
Last. Rosemary A. DodgeH-Index: 5
view all 3 authors...
Endocarditis caused by lactobacilli may lead to death or to relapse of infection, despite antimicrobial treatment. We report two cases of lactobacillus endocarditis in individuals with native bicuspid aortic valves who survived without relapse and review the 39 other cases reported in the literature. In only 15 previously reported cases have patients been cured with medical therapy alone. One of our patients, who was infected with Lactobacillus acidophilus, was cured by medical therapy alone, an...
93 CitationsSource
51 CitationsSource
#1Shimon Kusne (University of Pittsburgh)H-Index: 66
#2J S DummerH-Index: 5
Last. Monto HoH-Index: 62
view all 9 authors...
We studied infections in 101 consecutive patients who underwent liver transplantation between July 1984 and September 1985. The mean length of follow-up was 394 days. Eighty-three percent of the population had 1 or more episodes of infection and 67% of the population had severe infections. The overall mortality was 26/101 (26%) and 23 of 26 deaths (88%) were associated with infection. Seventy percent of severe infections occurred in the first 2 months after transplantation. The most frequent sev...
443 CitationsSource
#1Arnold S. BayerH-Index: 96
#2Anthony W. ChowH-Index: 52
Last. Lucien B. GuzeH-Index: 24
view all 4 authors...
Abstract Serious infections due to lactobacilli have been rarely cited. We report our findings in nine recent patients with lactobacillemia. In the combined literature and current experience, endocarditis and sepsis from localized suppuration were the most common clinical syndromes, most frequently arising from prior oropharyngeal infections. Lactobacillus endocarditis showed a predilection for leftsided cardiac involvement (100 per cent) and systemic arterial embolization (55 per cent). The nin...
127 CitationsSource
Cited By43
#1Paulo José Basso (USP: University of São Paulo)H-Index: 10
#2Niels Olsen Saraiva Câmara (USP: University of São Paulo)H-Index: 47
Last. Helioswilton Sales-CamposH-Index: 13
view all 3 authors...
Inflammatory bowel disease (IBD) is a group of multifactorial and inflammatory infirmities comprised by two main entities: Ulcerative colitis (UC) and Crohn’s disease (CD). Classic strategies to treat IBD are focused on decreasing inflammation besides of inducing and extending disease remission. However, these approaches have several limitations such as low responsiveness, excessive immunosuppression and refractoriness. Despite the multifactorial causality of IBD, immune disturbances and intesti...
50 CitationsSource
The initiation of intestinal inflammation involves complex intercellular cross-talk of inflammatory cells, including the epithelial and immune cells, and the gut microbiome. This multicellular complexity has hampered the identification of the trigger that orchestrates the onset of intestinal inflammation. To identify the initiator of inflammatory host–microbiome cross-talk, we leveraged a pathomimetic “gut inflammation-on-a-chip” undergoing physiological flow and motions that recapitulates the p...
92 CitationsSource
#1Satoshi AraiH-Index: 1
#2Junichi MinamiH-Index: 5
Last. Fumiaki AbeH-Index: 3
view all 7 authors...
In this study, the safety of Bifidobacterium breve MCC1274, a probiotic bifidobacterial strain, was assessed by single-dose and 90-day repeated-dose oral toxicity studies. In the single-dose oral toxicity assay using 6000 mg/kg of B. breve MCC1274 corresponding to 8.4 × 1011 colony-forming unit (CFU)/kg, mortality and adverse effects were not observed. Furthermore, the administration of 1000 mg/kg of B. breve MCC1274 by oral gavage in saline for 90 days did not induce any signs of toxicity, such...
#1Paurush Ambesh (Maimonides Medical Center)H-Index: 8
#2Sarah Stroud (Maimonides Medical Center)H-Index: 1
Last. Stephan Kamholz (Maimonides Medical Center)H-Index: 9
view all 7 authors...
Lactobacillus species are a commensal flora of the human gastrointestinal and the female genitourinary tract. Lactobacilli especially the rhamnosus species, are common components of commercial prob...
9 CitationsSource
#1Qianpeng Zhang (SJTU: Shanghai Jiao Tong University)H-Index: 7
#2Yanqiu Wu (SJTU: Shanghai Jiao Tong University)H-Index: 6
Last. Chenhong Zhang (SJTU: Shanghai Jiao Tong University)H-Index: 24
view all 12 authors...
Butyrate-producing bacteria (BPB) are potential probiotic candidates for inflammatory bowel diseases as they are often depleted in the diseased gut microbiota. However, here we found that augmentation of a human-derived butyrate-producing strain, Anaerostipes hadrus BPB5, significantly aggravated colitis in dextran sulphate sodium (DSS)-treated mice while exerted no detrimental effect in healthy mice. We explored how the interaction between BPB5 and gut microbiota may contribute to this differen...
97 CitationsSource
#1Alessandro Di CerboH-Index: 16
#2Beniamino Palmieri (University of Modena and Reggio Emilia)H-Index: 28
Last. Tommaso Iannitti (University of Sheffield)H-Index: 28
view all 5 authors...
The gut microbiome is not a silent ecosystem but exerts several physiological and immunological functions. For many decades, lactobacilli have been used as an effective therapy for treatment of several pathological conditions displaying an overall positive safety profile. This review summarises the mechanisms and clinical evidence supporting therapeutic efficacy of lactobacilli. We searched Pubmed/Medline using the keyword ‘Lactobacillus’. Selected papers from 1950 to 2015 were chosen on the bas...
117 CitationsSource
#1Simone MeiniH-Index: 11
#2Raffaele LaureanoH-Index: 1
Last. Gian Maria Rossolini (UniFI: University of Florence)H-Index: 94
view all 7 authors...
Background Probiotics are widely investigated in the treatment of various bowel diseases. However, they may also have a pathogenic potential, and the role of Lactobacillus spp. as opportunistic pathogens, mostly following disruption of the intestinal mucosa, is emerging.
42 CitationsSource
#1Giovanni CammarotaH-Index: 62
#2Gianluca IaniroH-Index: 36
Last. Diego Currò (CUA: The Catholic University of America)H-Index: 19
view all 6 authors...
Abstract Over the past recent years, a great number of studies have been directed toward the evaluation of the human host–gut microbiota interaction, with the goal to progress the understanding of the etiology of several complex diseases. Alterations in the intestinal microbiota associated with inflammatory bowel disease are well supported by literature data and have been widely accepted by the research community. The concomitant implementation of high-throughput sequencing techniques to analyze...
108 CitationsSource
Patients with inflammatory bowel disease (IBD) are a high risk population for bacteremia. Derangement in the mucosal architecture of the gastrointestinal (GI) tract and frequent endoscopic interventions in immunocompromised individuals are considered primary causes. Isolation of opportunistic microorganisms from the bloodstream of IBD patients has been increasingly reported in recent years. Leclercia adecarboxylata is a ubiquitous, aerobic, motile, gram-negative bacillus. The human GI tract is k...
10 CitationsSource